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Abstract
We apply a previously developed 4-variable ordinary differential equation model of in-host
immune response to pneumococcal pneumonia to study the variability of the immune
response of MF1 mice and to explore bacteria-driven differences in disease progression
and outcome. In particular, we study the immune response to D39 strain of bacteria missing
portions of the pneumolysin protein controlling either the hemolytic activity or complement-
activating activity, the response to D39 bacteria deficient in either neuraminidase A or B,
and the differences in the response to D39 (serotype 2), 0100993 (serotype 3), and TIGR4
(serotype 4) bacteria. The model accurately reproduces infection kinetics in all cases and
provides information about which mechanisms in the immune response have the greatest
effect in each case. Results suggest that differences in the ability of bacteria to defeat
immune response are primarily due to the ability of the bacteria to elude nonspecific clear-
ance in the lung tissue as well as the ability to create damage to the lung epithelium.
Introduction
Streptococcus pneumoniae, known as pneumococcus, continues to be a leading cause of mor-
bidity and mortality worldwide, particularly in children and the elderly. Pneumococci, which
are virulent encapsulated bacteria, are the most common cause of bacterial pneumonia [1]. The
capsule of these bacteria, composed almost entirely of polysaccharides, shields the bacteria
from several host defense mechanisms and contributes significantly to the virulence of pneu-
mococci [2–4]. In fact, encapsulated strains are about 100,000 times more virulent than strains
without a capsule [5,6].
The virulence of encapsulated bacteria depends on capsule thickness and chemical composi-
tion. A thicker capsule is advantageous in that it allows the bacteria to evade phagocytosis by
immune cells such as neutrophils or macrophages [7]. However, thicker capsules also impede the
ability of the bacteria to migrate from lung tissue to the bloodstream, decreasing their ability to
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cause bacteremia [8]. Bacteria in blood tend to proliferate faster than in tissue [9,10], and the num-
ber of activated phagocytes in the blood is proportionally lower than the number which migrate
into infected tissue. Thus, even though a thinner capsule leaves the bacteria more vulnerable to
phagocytosis, a thin capsule may also be advantageous for survival in some host species. Because
of this dichotomy, pneumococcal serotypes have evolved with a range of capsule thicknesses.
In addition to capsule thickness, the chemical composition of the capsule is significant to
bacterial fitness. Serotypes of pneumococcus are distinguished by the presence of specific gly-
coprotein motifs present on the surface of the capsule that influence the activation of the com-
plement [11,12], degradation of complement components [13], and resistance to phagocytosis
[14]. To date, over 90 serotypes of pneumococcus have been identified [15]. Each serotype can
induce a different reaction from the immune system, depending on the makeup of the capsule
and the activity of virulence factors associated with the bacterial surface.
Aside from the capsule, there are additional virulence factors, present both on the surface
and within the bacterium, which play an important role in the ability of the bacteria to evade
the immune system. Examples of such virulence factors are pneumolysin and neuraminidase.
Pneumolysin is a pore-forming toxin expressed by virtually all serotypes of pneumococcus
[16]. In early stages of the infection, when bacteria exist in low levels in the body, pneumolysin
is cytotoxic, causing apoptotic activity in the epithelial cells [17] and activation of the comple-
ment system [18]. As the infection progresses and pneumolysin concentration reaches higher
levels, it is lytic to any cell with cholesterol in the membrane [19]. This lytic action causes dam-
age to the tissue, and surrounding epithelial cells will increase the cytokine signaling to activate
immune cells. In the absence of pneumolysin, the influx of phagocytic cells is delayed and
decreased [20]. Neuraminidase is a surface protein that promotes the attachment of the bacte-
ria to the epithelium. Neuraminidase cleaves the terminal sialic acid from glycolipids and gly-
coproteins, which damages the epithelium, exposes more potential binding sites for the
bacteria, and promotes colonization [21,22]. Pneumococci have two neuraminidases on their
surfaces: neuraminidase A (NanA) and neuraminidase B (NanB) [23]. Though bacteria defi-
cient in either NanA or NanB are unable to cause sepsis in mice, NanA-deficient (NanA−) bac-
teria have been shown to cause less damage than NanB− bacteria [23].
The present study explores differences in host response to pneumococcus infection of the lung
for a selected number of pneumococcal serotypes and virulence factors using an ordinary differen-
tial equation (ODE) model described in our earlier work [24]. We have previously shown this
model to accurately predict bacteria levels in the lungs and blood of four strains of mice (CBA/Ca,
MF1, BALB/c, C57BL/6) inoculated with an identical strain of bacteria (D39). We now present a
complementing study, showing our model can accurately predict bacterial behavior for a single
strain of mouse (MF1) infected with one of several different types of pneumococci. We first explore
the response to D39 (serotype 2) bacteria missing portions of the pneumolysin protein controlling
either the hemolytic activity (H2-/C+) or complement-activating activity (H+/C-) [25]. Next, we
model the response to D39 bacteria deficient in either NanA or NanB [23]. Lastly, we explore the
response to three different serotypes of pneumococcus: D39 (serotype 2), 0100993 (serotype 3),
and TIGR4 (serotype 4) bacteria [26]. Notably, a change in few key parameters expressing the
activity of immune response components and virulence factors in our 4-variable ODEmodel cap-
tures the differences in the progression of infection exhibited by each phenotype of bacteria.
Results
Overview of modeling strategy
The ODE model used in this study was first presented in Mochan et al., 2014 [24]. The model
follows the time-dependent trajectories of bacterial populations in both the lung (PL) and the
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blood (PB) compartments, damage to the epithelial cells lining the lung (D), and total activated
phagocytic cells levels (N). These populations are modeled with 4 differential equations that
depend on 17 parameters. In each of our three studies (pneumolysin activity study, neuramini-
dase study, and serotype study), we define a subset of the model parameters as “bacterial-
strain-dependent”. These parameters are chosen based on existing knowledge of the mecha-
nisms of immune response regulation so as to account for expected phenotypic differences
seen in the progression of disease caused by each strain of bacteria modeled in the study. All
other parameters are defined as “bacterial-strain-independent”; these parameters, which
include parameters governing phagocyte lifespan, bacteria growth rates, threshold parameters,
and parameters inherent to host tissue, are assumed not to differ across strains of bacteria.
Table 1 summarizes the bacteria-strain-dependent parameters for all three sub-studies.
Though each study focuses on different types of bacteria, our method for analyzing the data
is uniform across all three studies. First, we estimate the uncertainty in parameter values by
using a Bayesian inference approach coupled with Metropolis-Hastings Monte Carlo sampling,
and compute a posterior distribution in parameter space. This posterior distribution forms a
model ensemble, a collection of generated parameter sets compatible with both the data and
the biological heuristic constraints. Then, we compute the ensemble of trajectories fitted to the
data for each type of bacteria, and full marginal posterior distributions for all bacteria-strain-
dependent parameters, illustrating the primary causes for differences in immune responses
seen for each bacterial phenotype. Finally, we use singular value decomposition of each ensem-
ble to describe the eigenvectors. Important components to the eigenvector associated with the
smallest eigenvalue identify parameters that are key drivers of the biological response.
Pneumolysin activity study
In the study of Jounblat et al., [25], female MF1 mice were infected with D39 bacteria to study
the impact of pneumolysin on the survival of bacteria in the body. The study involved wild-
type D39 and two mutant strains: H+/C-, in which pneumolysin lacks its complement-activat-
ing activity, and H2-/C+, in which pneumolysin has substantially reduced hemolytic (pore-
forming) activity. The C location on the pneumolysin protein activates the classical comple-
ment pathway [27]. Decreased activation of complement leads to decreased phagocytic activity
in both compartments and decreased activation of nonspecific immunity. In our model, these
effects are controlled by h, the rate at which phagocytes are activated by lung bacteria; ν, the
rate of nonspecific clearance of bacteria from the lungs by mucociliary clearance and resident
macrophages; ξnl, the rate at which phagocytes clear bacteria from the lungs; and ξnb, the rate at
which phagocytes clear bacteria from the blood. The H segment of the pneumolysin controls
the hemolytic activity of the bacteria, and hence the rate at which damage to the epithelium
increases due to the presence of bacteria in the lungs, which is in our model represented by
parameter q, We therefore fit the model to the pneumolysin study data by allowing only h, ν,
ξnl, ξnb, and q to vary across the bacterial strains.
Fig 1 displays the ensemble fits to data for wild-type, H+/C-, and H2-/C+ D39 bacteria. On
each ensemble trajectory plot, we represent the median trajectory as a solid black line, with the
Table 1. Summary of bacteria-strain-dependent parameters in each of the three studies presented.
Study Parameters varied between strains Reference
Pneumolysin activity h, q, ν, ξnl, ξnb [25]
Neuraminidase q, ν, a, ξnl, ξnb [23]
Serotype h, q, a, ν, ξnl, ξnb [26]
doi:10.1371/journal.pone.0134012.t001
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25–75% quantiles in dark gray and 5–95% percentiles in light gray. Mean experimental data
are represented by the black triangles, with standard deviations presented by the error bars.
In both lung and blood, each strain exhibits distinct behavior in the first 12 hours post-
infection. The H+/C- bacteria stay at a near constant high level for the first 12 hours and reach
the bloodstream in only 2 hours. The H2-/C+ bacterial population remains essentially level in
the lungs until a sharp decrease at 12 hours, while showing negligible levels in the blood during
that time. Bacterial populations in both compartments then begin to rise quickly, as transport
between compartments increases and the bacteria can more easily avoid the immune system.
The wild-type bacteria exhibit a gradual, steady decline in lung population levels. Wild-type
bacteria reach the blood in about 6–8 hours post-infection. As Fig 1 shows, the model captures
all these behaviors within the ensemble.
We next explore differences in the posterior distributions of the bacteria-strain-dependent
parameters (Fig 2A). H+/C- bacteria distributions (Fig 2A, top row) show a bimodal response
of the phagocytes, and the pairwise parameter correlations in Fig 2C indicate these parameters
are inversely correlated. Thus, when lung phagocytosis rates (ξnl) are high, blood phagocytosis
(ξnb) tends to be less effective, and vice versa. Since this strain lacks complement activation, we
Fig 1. Ensemble trajectories of pneumolysin activity study. Ensemble fits of each strain for lung pathogen (PL), blood pathogen (PB), epithelial damage
(D), and activated phagocytic cells (N). The black line represents the median trajectory, the inner dark gray area represents the 25th to 75th quantiles of
trajectories, and the outer light gray envelope represents 90% of the trajectories (5th to 95th quantiles). Data points with standard deviations are represented
by the black triangles with error bars. Data were taken at 0, 3, 6, 12, 24, and 48 hours post-infection with ten mice in each group. Trajectories are simulated
over two days, with infection occurring on day 0. The top row shows ensembles for H+/C- bacteria, the middle row shows ensembles for H2-/C+ bacteria, and
the bottom row shows ensembles for the wild-type (WT) bacteria.
doi:10.1371/journal.pone.0134012.g001
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would expect a generally low level of phagocytic activity. Interestingly, even though this strain
has full hemolytic activity, the distribution of the damage production rate q exists in the lower
half of its bounds. This likely occurs because lung bacteria levels remain high throughout the
full course of the infection, and thus the values for q do not need to be exceedingly high in
order to produce movement into the blood compartment.
H2-/C+ bacteria distributions (Fig 2A, middle row) have full complement-activating capabil-
ity, so they show relatively high levels of phagocytic activation (h) and response (ξnl). Nonspe-
cific clearance (ν) tends to be low for this strain, allowing the bacteria to persist in the lungs at a
constant level for the first 8 hours post-infection. The lack of hemolytic activity in this bacterial
strain is associated with a low level of damage production q. In contrast, wild-type bacteria dis-
tributions (Fig 2A, bottom row) exhibit high levels of damage production, phagocytic activation,
and nonspecific clearance. The pneumolysin of this strain possesses its full hemolytic and com-
plement-activating activity. Clearance of the wild-type bacteria in the blood is low, as the bacte-
ria reach the blood and remain at high levels after about 12 hours post-infection.
We next study the eigenvalues of the system through singular-value decomposition (Fig
2B). Since we see no large difference in the singular values associated with the final two princi-
pal components, we conclude that a principal component analysis would not be beneficial to
Fig 2. Analysis of bacteria-dependent parameters in the pneumolysin activity study. (A) One-dimensional parameter distributions of bacteria-
dependent parameters: h, q, ν, ξnl, ξnb. The top row (green) shows ensembles for H+/C- bacteria. The middle row (red) shows ensembles for H2-/C+ bacteria.
The bottom row (blue) shows ensembles for wild-type (WT) bacteria. (B) Principal values computed from singular-value decomposition of ensembles for
each bacterial strain. (C-E) Two-dimensional parameter correlations for H+/C- (C) H2-/C+ (D) and wild-type (E) bacteria.
doi:10.1371/journal.pone.0134012.g002
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this study, as there is no clear stiff direction in parameter space. Instead, we present two-
dimensional parameter correlations for the strain-dependent parameters for each bacteria
strain (Fig 2C–2E). Fig 2C more clearly shows the bimodality exhibited by the H+/C- ensem-
ble. The ensembles for H2-/C+ (Fig 2D) and wild-type (Fig 2E) show few correlations of inter-
est, as these distributions tend to be tighter than those of the H+/C- ensemble.
Neuraminidase study
In the study of Manco et al. [23], mice were first infected intranasally with 107°CFU of either
wild-type, NanA−, or NanB− D39 pneumococcus. NanA− bacteria are cleared from the lungs
by 12 hours post-infection, while NanB− bacteria persist for up to 48 hours post-infection but
are eventually cleared by the immune system. Wild-type bacteria overwhelm the immune sys-
tem and cause death about 24 hours post-infection. We select the following parameters to
explain the behavior of neuraminidase in the intranasal infection: q, the rate of increase of
damage to epithelium; ξnl, the rate of intrapulmonary phagocytosis; and ν, the nonspecific
clearance of bacteria in the lungs. Changes in q and ν would represent a decreased ability of the
bacteria to bind to the epithelium in the absence of neuraminidase, and some studies also sug-
gest neuraminidase can stimulate resistance to opsonization by neutrophils [28], which would
impact the value of ξnl. We hypothesize that the wild-type bacteria should cause the most dam-
age to the epithelium, as this strain has full ability to bind to the epithelium. We would expect
higher rates of clearance and lower damage creation from the mutant strains.
Following the intranasal infection, neither NanA− nor NanB− bacteria were able to be iso-
lated from the blood [23]. To better explore the role of neuraminidase in the blood vessels,
Manco et al. also infected MF1 mice intravenously with 105 CFU of one of these bacterial
strains. Again, the neuraminidase-deficient bacteria are unable to cause a serious infection, as
they are cleared from the blood within 2 days post-infection. Wild-type bacteria, however, are
again able to cause serious bacteremia and therefore lead to morbidity around 2 days post-
infection. We select a, the damage-independent rate of bacterial migration from blood to tissue,
and ξnb, the rate of extrapulmonary phagocytosis, to explain the results of the intravenous
infection experiment. Neutrophil opsonization would again be limited by the presence of neur-
aminidase in the wild-type bacteria, and neuraminidase-deficient bacteria would not be able to
migrate between compartments easily, as they lack a basic component of adhesion to the epi-
thelial wall. We fit both the intranasal and intravenous data simultaneously for all three strains
of bacteria. For the intranasal case, we use an initial condition of 107 CFU for PL and 0 CFU for
PB, and for the intravenous case, we use an initial condition of 0 CFU for PL and 10
5 CFU for
PB, consistent with experimental conditions. The model is fit to data for both cases simulta-
neously, thus generating only one set of parameter distributions for each strain of mouse in the
neuraminidase study.
Fig 3 shows the ensemble fits to intranasal infection data for wild-type, NanA−, and NanB−
D39 bacteria. NanA− bacteria are unable to adequately bind to the epithelium, and they are
cleared from the lungs within 12 hours. NanA− bacteria are unable to cause any appreciable
damage or sustain a population in the blood for more than a few hours in our predicted trajec-
tories. Experiments verified that these bacteria were not detected in the blood at any point in
the experiments. NanB− bacteria can persist in the lungs longer than NanA−, but these bacteria
will eventually clear as well. While our ensembles show some presence of bacteria in the blood,
these bacteria are cleared within about one day, thus not causing severe bacteremia, again
aligning with the findings of the authors [23]. The wild-type bacteria are highly virulent, caus-
ing sepsis and eventual death to the mice about 1 day post-infection. Our ensembles match the
lung data well and show a quick rise in blood bacteria levels as well as epithelial damage.
Murine Immune Response to Multiple Pneumococcal Strains
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Though the activated phagocytic cell population is highest in the simulated wild-type bacteria
ensemble, these cells are unable to contain the bacterial population in either compartment.
Fig 4 demonstrates the ensemble solutions for the intravenous infection experiments. Bacte-
ria are introduced into the blood at day 0 at an initial level of 105 CFU. NanA− bacteria are
cleared from the blood within about 12 hours post-infection, and while they are able to reach
the lungs relatively quickly, they are cleared from the tissue quickly as well. NanB− bacteria
show an initial steep drop in blood levels as they move into the lungs. These bacteria are not
fully cleared from the blood until about 2 days post-infection. While the lung bacteria levels
have not been eliminated at this point, all trajectories will eventually lead to total clearance of
bacteria from both compartments. Again, the wild-type bacteria are the most virulent in these
experiments. These are the only bacteria able to cause significant damage, and as such the bac-
teria levels in both compartments rise over the first 12 hours until they hit a carrying capacity
in the blood and cause morbidity of the host.
Distributions of our bacteria-dependent parameters show marked differences across these
three strains (Fig 5A). NanA− bacteria are essentially insensitive to q and a, as the bacteria are
unable to maintain their population for more than a few hours in either the intranasal or the
Fig 3. Ensemble trajectories of neuraminidase study with intranasal infection data. Ensemble fits of each strain for lung pathogen (PL), blood pathogen
(PB), epithelial damage (D), and activated phagocytic cells (N). The black line represents the median trajectory, the inner dark gray area represents the 25
th to
75th quantiles of trajectories, and the outer light gray envelope represents 90% of the trajectories (5th to 95th quantiles). Data points with standard deviations
are represented by the black triangles with error bars. Data were taken at 0, 2, 4, 6, 12, 24, and 48 hours post-infection with five mice in each group.
Trajectories are simulated over two days, with infection occurring on day 0 in the lungs. The top row shows ensembles for NanA− bacteria, the middle row
shows ensembles for NanB− bacteria, and the bottom row shows ensembles for the wild-type (WT) bacteria.
doi:10.1371/journal.pone.0134012.g003
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intravenous experiments. Clearance rates of the NanA− bacteria both by nonspecific means (ν)
and by phagocytic cells (ξnl, ξnb) tend towards the upper end of the spectrum, meaning these
bacteria are easily cleared by the immune system. This result is further verified by the evidence
that NanA prevents opsonization by neutrophils [28].
NanB− bacteria show the most sensitivity to a, the damage-independent movement of bacte-
ria from blood to lungs, as this distribution is the most narrow. Pulmonary clearance of the
NanB− bacteria (ν, ξnl) tends to be lower than that of the NanA
− bacteria. It is unclear whether
NanB has the same effect on opsonization as NanA; further experiments on the interactions of
NanB and neutrophils are needed in order to verify this prediction biologically. The clearance
of NanB− bacteria in the blood is generally very high, explaining the fast initial drop in blood
levels in the intravenous infection data.
The distributions for the wild-type bacteria differ most from the neuraminidase-deficient
bacteria in the values of a and ξnb, both of which are much lower than the distributions seen in
the other two strains. Both of these results align with our initial hypotheses; the presence of
NanA allows the wild-type bacteria additional resistance to phagocytosis, and the ability to
bind the epithelium and cause excess damage means the bacteria require less damage-
Fig 4. Ensemble trajectories of neuraminidase study with intravenous infection data. Ensemble fits of each strain for lung pathogen (PL), blood
pathogen (Pb), epithelial damage (D), and activated phagocytic cells (N). The black line represents the median trajectory, the inner dark gray area represents
the 25th to 75th quantiles of trajectories, and the outer light gray envelope represents 90% of the trajectories (5th to 95th quantiles). Data points with standard
deviations are represented by the black triangles with error bars. Data were taken at 0, 3, 6, 24, and 48 hours post-infection with five mice in each group.
Trajectories are simulated over two days, with infection occurring on day 0 in the blood. The top row shows ensembles for NanA− bacteria, the middle row
shows ensembles for NanB− bacteria, and the bottom row shows ensembles for the wild-type (WT) bacteria.
doi:10.1371/journal.pone.0134012.g004
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independent motion to overwhelm the lung and blood compartments. Interestingly, all three
strains show an insensitivity to q, despite the known increased ability of the wild-type bacteria
to adhere to the epithelium and create damage. The effect of this phenomenon is absorbed in
the parameter a; higher values of a imply lower levels of damage created.
The principal values of the system again show no significant difference between the final
two components (Fig 5B), so a principal component analysis would not provide interpretable
results. The two-dimensional parameter correlations (Fig 5C–5E) show a few noteworthy pat-
terns. NanA− bacteria exhibit a switching behavior with ν, a, and ξnl. When ν is high, then a
and ξnl are low, and vice versa. In addition, both NanB
− and wild-type bacteria show a strong
negative correlation between q and a.
Serotype study
In the study of McCluskey et al. [26], mice were given wild-type strains of either D39 (serotype
2), 0100993 (serotype 3), or TIGR4 (serotype 4) pneumococcus. These strains differ primarily
in the serotypes’ capsule thicknesses and virulence. In this study, we selected 6 parameters as
bacteria-strain-dependent: h, q, a, ν, ξnl and ξnb, since these parameters control the degree to
Fig 5. Analysis of bacteria-dependent parameters in the neuraminidase study. (A) One-dimensional parameter distributions of bacteria-dependent
parameters: q, a, ν, ξnl, ξnb. The top row (green) shows ensembles for NanA
− bacteria. The middle row (red) shows ensembles for NanB− bacteria. The
bottom row (blue) shows ensembles for wild-type (WT) bacteria. (B) Principal values computed from singular-value decomposition of ensembles for each
bacterial strain. (C-E) Two-dimensional parameter correlations for NanA− (C) NanB− (D) and wild-type (E) bacteria.
doi:10.1371/journal.pone.0134012.g005
Murine Immune Response to Multiple Pneumococcal Strains
PLOS ONE | DOI:10.1371/journal.pone.0134012 August 5, 2015 9 / 18
which bacteria can move between lung tissue and blood (q and a), as well as the degree to
which the host is able to fight these particular strains of pneumococcus (h, ν, ξnl, ξnb).
Fig 6 shows the ensemble trajectories fit to data for D39, 0100993, and TIGR4 bacteria up to
48 hours post-infection. Trajectories generally fit data tightly, with most variation in predicted
trajectories occurring in D and N. TIGR4 tend to create the most damage, while very little dam-
age is seen for the D39 ensemble. Each strain varies significantly in the first 12 hours, repre-
sented by the first data point. 0100993 bacteria remain relatively high, exhibiting little
nonspecific clearance. TIGR4 and D39 bacteria levels in the lung decrease by several orders of
magnitude during the first 12 hours, showing both a greater susceptibility to this initial clear-
ance and faster movement into the bloodstream.
Fig 7A shows the distributions of bacteria-strain-dependent parameters for each of the
three serotypes. The largest disparities between strains exist in distributions for a, ξnl, ξnb and ν
populations. 0100993 bacteria tend to have a low value for a, the damage-independent move-
ment of bacteria from the bloodstream to the tissue. Since these serotype 3 bacteria typically
remain higher in the lung tissue than in the blood, we would expect the effect of this motion to
be minimal. In contrast, TIGR4 bacteria tend to have a high a value, as these bacteria readily
Fig 6. Ensemble trajectories of serotype study. Ensemble fits of each strain for lung pathogen (PL), blood pathogen (PB), epithelial damage (D), and
activated phagocytic cells (N). The black line represents the median trajectory, the inner dark gray area represents the 25th to 75th quantiles of trajectories,
and the outer light gray envelope represents 90% of the trajectories (5th to 95th quantiles). Data points with standard deviations are represented by the black
triangles with error bars. Data were taken at 12, 24, and 48 hours post-infection with three mice in each group. Trajectories are simulated over two days, with
infection occurring on day 0 in the blood. The top row shows ensembles for 0100993 bacteria, the middle row shows ensembles for TIGR4 bacteria, and the
bottom row shows ensembles for the D39 bacteria.
doi:10.1371/journal.pone.0134012.g006
Murine Immune Response to Multiple Pneumococcal Strains
PLOS ONE | DOI:10.1371/journal.pone.0134012 August 5, 2015 10 / 18
cause sepsis. D39, known to cause both severe pneumonia and sepsis in MF1 mice, have a val-
ues concentrated between these two extremes.
Each serotype also differs in its resistance to clearance by both mucosal immunity and
phagocytic activity. The distribution for D39 ν aligns with the MF1 output from our previous
work [24]. Higher values of ν are evident in 0100993 and TIGR4 bacteria. Phagocytosis rates
(ξnl and ξnb) also vary between these serotypes. Phagocytosis in the tissue tends to be low for
the 0100993 bacteria, high for TIGR4, and D39 lies somewhere in the middle. Extrapulmonary
phagocytosis is high in both 0100993 and D39 and slightly lower for TIGR4.
We perform singular value decomposition on the ensemble, and from the output determine
the makeup of each principal component and eigenvalues associated with each. The steep drop
in the magnitude of the eigenvalue associated with the final principal component suggests that
the composition of the final principal component explains most of the sensitivity of the model
(Fig 7B). We study the makeup of this vector to determine which parameters contribute most
to this sensitivity (Fig 7C). The relative contribution of each element to the vector is repre-
sented in a pie chart, and the color of each piece denotes whether the parameter has a positive
(cool colors) or negative (warm colors) contribution.
Fig 7. Analysis of bacteria-dependent parameters in the sesrotype study. (A) One-dimensional parameter distributions of bacteria-dependent
parameters: h, q, a, ν, ξnl, ξnb. The top row (green) shows ensembles for 0100993 bacteria. The middle row (red) shows ensembles for TIGR4 bacteria. The
bottom row (blue) shows ensembles for D39) bacteria. (B) Principal values computed from singular-value decomposition of ensembles for each bacterial
strain. (C-E) Composition of the last principal component for 0100993 (C) TIGR4 (D) and wild-type (E) bacteria. Warm colors represent a negative
contribution to sensitivity, and cool colors represent a positive contribution.
doi:10.1371/journal.pone.0134012.g007
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Strain 0100993 is most sensitive to ν. Serotype 3 strains tend to stay in the lungs to cause
severe pneumonia [29], so a sensitivity to clearance in the tissue is expected. The TIGR4
ensemble is most sensitive to ν, ξnb, q and a. TIGR4 bacteria are known to cause bacteremia
and sepsis very quickly in mice, and eventually progress to cross the blood-brain barrier, lead-
ing to meningitis [29]. These sensitive parameters control the ability of the bacteria to prolifer-
ate in the lungs, cause epithelial damage, and move between the lung and blood compartments.
Lastly, the D39 ensemble is most sensitive to q. D39 is known to be highly virulent to mice,
often leading to both sepsis and severe pneumonia [29,30]. Since bacterial replication in lung
tissue is highly dependent on the ability of the bacteria to move to the blood and evade phago-
cytosis, we would expect the rate of damage creation to be critical to explain the data.
Discussion
In the present study we further develop a recently proposed ODE model of intrahost immune
response to pneumococcal pneumonia [24]. We demonstrate the selection of a parsimonious
subset of parameters that can define primary differences between bacterial strains. We here
show that the model is capable of capturing differences not only across murine strains (as
described in [24]), but also across bacterial strains. Our model identifies differences in immune
response to infection by bacteria missing a portion of a protein (pneumolysin activity study), a
whole protein (neuraminidase study), or entirely different serotypes (serotype study). The
model can also describe initial decay and subsequent dramatic rise in the number of pneumo-
cocci in the lungs, which has been observed experimentally as coordinated with a similar rise in
the blood.
While a different subset of five or six parameters was identified as bacteria-dependent in
each study, four parameters were consistently bacteria-dependent in all of our three studies: ν,
q, ξnl and ξnb. The parameter ν incorporates nonspecific clearance mechanisms such as muco-
ciliary clearance, alveolar macrophage activity, defensins and other proteins active in mucosal
immunity. The pneumolysin study demonstrated differences in ν for all three bacterial strains,
with high ν values seen in the wild-type bacteria ensembles and low ν values in the H2-/C
+ ensembles. Absence of hemolytic activity in the H2-/C+ bacteria could be responsible for a
decreased activation of the alveolar macrophages, thereby decreasing the overall rate of clear-
ance by ν. In the neuraminidase study, ν tended to be lowest for NanB− bacteria. These bacteria
have not been studied extensively, so reasons for this difference are unclear.
In the serotype study, ν stood out as a highly sensitive parameter for both TIGR4 and
0100993 bacteria. TIGR4 bacteria are highly virulent, so likely the host must have strong non-
specific defenses to control TIGR4 levels from the beginning of the infection. Another viru-
lence factor impacting the nonspecific clearance is choline-binding protein. Choline-binding
proteins allow bacteria to anchor themselves to the epithelial surface, increasing their ability to
avoid non-specific clearance mechanisms. Brooks-Walter et al. showed that about 25% of
pneumococcal strains do not express choline-binding protein A (CbpA, also known as PspC or
SpsA), which can limit virulence [31]. It has been shown that another serotype 3 strain, A66.1,
does not express CbpA, so it is possible that our serotype 3 strain, 0100993, also does not. This
would explain the need for such a high inoculum to generate survival rates similar to those
seen in the other infections; an inoculum of 107°CFU of 0100993 was required, compared to
only 105 CFU of TIGR4, suggesting decreased virulence in the serotype 3 strain.
The parameter q, the rate at which lung bacteria create damage to the epithelium, was found
to be strain-dependent in all three studies. While q was not an influential parameter in the
neuraminidase study, it was crucial to the ensemble fits for the wild-type D39 bacteria in the
pneumolysin and serotype studies. D39 is often used in murine models of pneumonia because
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it is known to be highly virulent to mice, leading to both severe pneumonia and bacteremia.
We would therefore expect to see damage creation as a highly important factor in the pheno-
type associated with D39 infection. The q distribution for wild-type D39 tends to be skewed
high in the pneumolysin study but exists over the full parameter range in the serotype study.
We can see large differences in the D39 bacteria levels between the two studies, possibly due to
different laboratory conditions, different protocols used, or different sources of the materials
and specimens used in the study. These differences are enough to induce distinct parameter
distributions for each wild-type ensemble.
The rates of phagocytic clearance in lung tissue and blood (ξnl and ξnb, respectively) were
also found to be bacteria-dependent parameters in each of the three studies. Many virulence
factors present on the bacterial surface allow the bacteria to avoid phagocytosis, and since the
presence and efficacy of these virulence factors varies across strains, we would expect these
parameters to greatly influence the ensembles. In the pneumolysin study, because the biggest
variations in the data occur in the first 12 hours, phagocytic cells do not control the major dif-
ferences in the ensembles; these effects are felt more strongly later in the course of the infection.
In the neuraminidase study, wild-type bacteria are not cleared effectively in the blood, while
the neuraminidase-deficient strains show very high levels of blood clearance. Neuraminidase A
is known to decrease efficacy of neutrophil killing [28], so it is possible neuraminidase B has a
similar effect on the host. Our ensembles do not demonstrate such a stark contrast in the intra-
pulmonary phagocytosis rates, however. A lower intensity of immune response in the lungs is
sufficient to clear the bacteria.
We have utilized experimental data for neutrophil levels and for bacterial levels in the lungs
and in the blood to calibrate the model. We have not fit the trajectory of the damage variable to
any data and therefore this trajectory is a prediction of the model that can be potentially used
to validate our results. There are several ways that damage to epithelium can be monitored; one
possibility is by means of a biomarker such as decreased lung capacity or decreased epithelial
cell cilia [32,33]. The other possibility is to use histological samples to assess the level of epithe-
lial damage. The addition of damage level data to future uses of the model could change the dis-
tributions of q, possibly making them to be tighter to adhere to a particular range of data.
The ensemble model approach to data analysis can accommodate uncertainty in data, but it
does have limitations. Our equation-based model might be considered complex by some
researchers (it requires 17 parameters), yet, even so, it greatly simplifies the actual biology of
the immune response. For example, parameter ν lumps several different mechanisms involved
in mucosal immunity, only one type of immune cells is assumed to remove pathogens, and we
do not directly account for intercellular signaling. Unfortunately, experimental datasets
required to parametrize more complex and biologically accurate models describing these
mechanisms currently do not exist. Accordingly, we perceive our contribution as hypothesis-
generating and as a basis for guiding future mechanistically-based experimentation. Future
iterations of the model could address some of these simplifying assumptions, perhaps provid-
ing for a more detailed account of the host immune system. Another important assumption of
the model is that, within the lung or blood compartments, the system is well-mixed. In reality,
there is a spatial component to bacterial infections that this simple model is unable to capture.
Future models may allow for this spatial heterogeneity to be incorporated into the dynamics.
In conclusion, we have presented an important extension of our previously proposed model
that shows its utility not only in modeling how different hosts response to the same bacterial
infection, but also how identical hosts respond to multiple types of bacterial infections. Our
model is able to capture the initial decay followed by quick rise in lung bacterial loads associ-
ated with a rise in blood bacterial loads. We have demonstrated how the parameters of our
model can be used to analyze and predict the immune responses of the host to each type of
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bacteria. This work provides a path forward for future work modeling the response to different
bacterial strains or adding complexity to the model by incorporating more components of the
immune system explicitly in the equations.
Methods
Experimental data
The model is calibrated to literature data [23,25,26] for female MF1 mice given an intranasal
dose of pneumococcus. The pneumolysin study uses data of Jounblat et al., [25], where mice
were infected with D39 bacteria to study the impact of pneumolysin on the survival of bacteria
in the body. Mice were given a dose of 106 CFU of either wild-type D39 or one of two mutant
strains: H+/C- or H2-/C+. H+/C- mutants feature pneumolysin that lacks the complement-
activating activity but have no change to the hemolytic activity. In contrast, H2-/C+ mutants
have full complement-activating activity but exhibit only 0.02% of normal pore-forming activ-
ity. Data are given for bacterial populations in both the lung tissue and blood at 0, 3, 6, 12, 24,
and 48 hours post-infection. The neuraminidase study utilizes data fromManco et al. [23],
where mice were infected with 107°CFU of either wild-type, neuraminidase A deficient
(NanA−), or neuraminidase B deficient (NanB−) D39 pneumococcus. Data are given only for
bacterial populations in the lung tissue for 0, 2, 4, 6, 12, 24, and 48 hours post-infection. The
serotype study incorporates data fromMcCluskey et al. [26], where mice were given wild-type
strains of either 106 CFU of D39, 107 CFU of 0100993, or 105 CFU of TIGR4 pneumococcus.
Data are given for bacterial load in lungs and blood at 12, 24, and 36 hours post-infection.
Mathematical model
In the intranasal infection data, bacteria are introduced intranasally into the lung tissue, where
they quickly attach to the epithelium and begin to reproduce. The first line of defense against
these bacteria is nonspecific immunity, such as resident alveolar macrophages and mechanical
clearance via the mucociliary elevator. Together, these defenses can clear low levels of bacteria
without the need for an additional influx of immune cells. If bacteria levels are too high for
nonspecific clearance alone, lung epithelial cells will signal an influx of white blood cells, pri-
marily neutrophils [34]. These phagocytes will become activated and move to the site of
infected tissue. Though phagocytes will ingest bacteria as they move through the bloodstream
to the lungs, the majority of their work will occur in the lung tissue. When bacteria adhere to
the epithelium, they cause increased cell death and damage to the epithelium. This damage
facilitates the exchange of bacteria between tissue and blood by increasing the permeability of
the epithelium [32,33]. Bacteria can also move in a damage-independent motion; bacteria in
the blood have a tendency to move back to tissue to colonize [35].
These mechanisms were utilized by Mochan et al. [24] in the development of a four equa-
tion ODE model used there and also in this study. The model predicts the time-dependent tra-
jectories for four variables: bacterial load in lung tissue (PL), bacterial load in blood (PB),
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In the model, bacteria in the lungs grow at a linear rate with constant kl, and are removed by
(i) mechanical clearance via cilia and mucus and phagocytosis by alveolar macrophages, modeled
with rate constant ν and saturation constant μ, and by (ii) neutralization by phagocytes (N) with
rate constant ξnl and saturation constant ξ2. Movement of bacteria between lungs and blood is
described by the last two terms, where f describes the volumetric difference between the blood
and lung compartments, a describes the damage-independent rate of movement of the blood
bacteria into the lung compartment, and b is the permeability of the membrane to the bacteria,
describing the damage-dependent movement. Blood pathogen (PB) grows logistically with rate
constant kb, carrying capacity K, and the Allee threshold ε that represents the extinction limit.
Blood pathogens are removed by phagocytes (N) in the blood with rate constant ξnb and satura-
tion constant ξ2. Like the previous equation, the final terms describe damage-dependent and
damage-independent motion of bacteria between the two compartments. Damage (D) increases
at a rate proportional to the amount of bacteria present in the lung, with rate constant q. The
body is able to repair damage at a linear rate with constant c. The damage varies only between 0
and 1. The dynamics of phagocytes (N) occurs on time-scale τN. Activation is proportional to the
population of lung pathogen. The activation and influx of the phagocytes is proportional to the
lung pathogen level with rate constant h, and saturates with a half-maximum value at nh.
Markov Chain Monte Carlo simulations
As in our previous work, we use Bayesian inference to estimate the posterior distributions of
each of the parameters of our model. For each of the three studies conducted, we have n bacte-
ria-strain-dependent parameters defined and 17−n bacteria-strain-independent parameters.
(See Table 1 for a full list of strain-dependent parameters assigned in each study.) Parameter
bounds are identical to those in our previous work, except for the bounds on parameters a and
K. Bounds on a have been widened to include values between 10−4−104. To reduce dimension-
ality, K, the carrying capacity of the bacteria, was kept at a constant 108 CFU in all iterations of
all studies. In our previous work, K was allowed to vary between 107 and 108 CFU. Here, we set
K to its upper bound of 108 CFU so that it would be unlikely to hinder any of our fits to these
bacterial strains, as some of the lung bacteria data used in this study reach a steady state value
close to 108 CFU. Table 2 shows the full ranges for each of the parameters in the model.
At each iteration of the algorithm, parameter vector p consists of 3n strain-dependent
parameter values (one set of n parameters for each type of bacteria used in the study) and 17−n
strain-independent parameter values. Bounds on the parameters were defined in biological
ranges where literature values could be determined and estimated for the other parameters.
To ensure the parameters chosen as strain-dependent are the most sensitive in each study,
we first sampled a posterior distribution in which we allowed all 17 parameters to vary between
each strain. We observed which parameters tended to localize to different areas of parameter
space and identify those as the most sensitive parameters. We then chose those parameters
strain-dependent [24] and resampled the posterior distribution.
Given the high dimensional space in which parameters must be sampled, we use a parallel tem-
pering algorithm [36–38]. We generated four million parameter sets for each of the three studies.
Convergence of the chains was verified with the Gelman-Rubin test [39] and the Geweke test [40].
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